411 related articles for article (PubMed ID: 26559522)
1. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
Gajra B; Patel RR; Dalwadi C
Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
[TBL] [Abstract][Full Text] [Related]
2. Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design.
Adena SKR; Upadhyay M; Vardhan H; Mishra B
Drug Dev Ind Pharm; 2018 Mar; 44(3):493-501. PubMed ID: 29161920
[TBL] [Abstract][Full Text] [Related]
3. Chitosan nanoparticles for the oral delivery of tenofovir disoproxil fumarate: formulation optimization, characterization and ex vivo and in vivo evaluation for uptake mechanism in rats.
Shailender J; Ravi PR; Reddy Sirukuri M; Dalvi A; Keerthi Priya O
Drug Dev Ind Pharm; 2018 Jul; 44(7):1109-1119. PubMed ID: 29409342
[TBL] [Abstract][Full Text] [Related]
4. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
Girotra P; Singh SK
AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.
Sharma M; Sharma R; Jain DK; Saraf A
Int J Biol Macromol; 2019 Aug; 135():246-260. PubMed ID: 31128197
[TBL] [Abstract][Full Text] [Related]
6. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
7. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Dudhipala N; Janga KY
Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Characterization, and Optimization of Folic Acid-Chitosan-Methotrexate Core-Shell Nanoparticles by Box-Behnken Design for Tumor-Targeted Drug Delivery.
Naghibi Beidokhti HR; Ghaffarzadegan R; Mirzakhanlouei S; Ghazizadeh L; Dorkoosh FA
AAPS PharmSciTech; 2017 Jan; 18(1):115-129. PubMed ID: 26896317
[TBL] [Abstract][Full Text] [Related]
9. Long-circulating polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for tumor targeted docetaxel delivery: Formulation, optimization and in vitro characterization.
Vardhan H; Mittal P; Adena SK; Mishra B
Eur J Pharm Sci; 2017 Mar; 99():85-94. PubMed ID: 28002762
[TBL] [Abstract][Full Text] [Related]
10. Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.
Jafarieh O; Md S; Ali M; Baboota S; Sahni JK; Kumari B; Bhatnagar A; Ali J
Drug Dev Ind Pharm; 2015; 41(10):1674-81. PubMed ID: 25496439
[TBL] [Abstract][Full Text] [Related]
11. Development and Evaluation of Chitosan Nanoparticles for Ocular Delivery of Tedizolid Phosphate.
Kalam MA; Iqbal M; Alshememry A; Alkholief M; Alshamsan A
Molecules; 2022 Apr; 27(7):. PubMed ID: 35408724
[TBL] [Abstract][Full Text] [Related]
12. Release Properties and Cellular Uptake in Caco-2 Cells of Size-Controlled Chitosan Nanoparticles.
Je HJ; Kim ES; Lee JS; Lee HG
J Agric Food Chem; 2017 Dec; 65(50):10899-10906. PubMed ID: 29172499
[TBL] [Abstract][Full Text] [Related]
13. "Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ".
Shah B; Khunt D; Misra M; Padh H
Int J Biol Macromol; 2016 Aug; 89():206-18. PubMed ID: 27130654
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo skin permeation and retention studies on chitosan-ibuprofen-gellan ternary nanogel prepared by in situ ionic gelation technique--a tool for controlled transdermal delivery of ibuprofen.
Abioye AO; Issah S; Kola-Mustapha AT
Int J Pharm; 2015 Jul; 490(1-2):112-30. PubMed ID: 25997660
[TBL] [Abstract][Full Text] [Related]
15. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
16. Early Stage HIV Management and Reduction of Stavudine-Induced Hepatotoxicity in Rats by Experimentally Developed Biodegradable Nanoparticles.
Ghosh S; Mondal L; Chakraborty S; Mukherjee B
AAPS PharmSciTech; 2017 Apr; 18(3):697-709. PubMed ID: 27222026
[TBL] [Abstract][Full Text] [Related]
17. Formulation and optimization of rifampicin microparticles by Box-Behnken statistical design.
Maurya DP; Sultana Y; Aqil M; Ali A
Pharm Dev Technol; 2012; 17(6):687-96. PubMed ID: 21486138
[TBL] [Abstract][Full Text] [Related]
18. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
19. Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery.
Saroha A; Pandey P; Kaushik D
Pharm Nanotechnol; 2017; 5(4):310-316. PubMed ID: 28847270
[TBL] [Abstract][Full Text] [Related]
20. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
Sharma A; Singh AP; Harikumar SL
Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
[No Abstract] [Full Text] [Related]
[Next] [New Search]